Category

• Events1
• Pipeline1

Organizations

• Bausch + Lomb46
• Eyes On Eyecare33
• American Optometric Association25
• Alcon, Inc.23
• Glaukos20
• Harrow20
• Aldeyra Therapeutics16
• Ocuphire Pharma16
• Sight Sciences16
• American Academy Of Ophthalmology15

Tags

• Cell Therapy2
• Clinical Trials2
• Cornea2
• Ophthalmology Tech Forum1
• Corneal Transplant1
• Genetic Testing1
• Inherited Retinal Disease1
• Ophthalmic Tech1
• Ophthalmology1
• Retina1

• organizations:Emmetrope Ophthalmics (Emmecell)✕

Clear all

Events

KOLs eye the future of genetic engineering and cell transplantation

Industry leaders from four leading ophthalmic companies debut the latest clinical developments in cell-based therapeutics.

Pipeline

Cell therapy dosing concludes for Emmecell's corneal edema trial

Minimally-invasive cell therapy has been designed to repopulate dysfunctional corneal endothelial cells, potentially eliminating the need for transplantation.